Corona Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/01/2026 ,inter alia, to consider and approve unaudited Financial Results ....
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Corona Remedies Ltd has informed BSE that its Board of Directors will meet on Friday, January 2, 2026, to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2025. The filing is a routine regulatory disclosure made under SEBI Listing Regulations. The company also reminded that the trading window for dealing in its securities, which opened on December 15, 2025, will close 48 hours after the financial results are announced. No actual financial numbers have been disclosed in this filing — only the date of the upcoming results announcement.
No direct impact on stock price from this filing alone, as it is a procedural notice. Investors should watch for the actual Q2/H1 FY26 results on or shortly after January 2, 2026, which will be the next material catalyst for the stock. The stock remains in a closed trading window until then.